Title : Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents.

Pub. Date : 2020

PMID : 30332940






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In this review, we summarize four major structural classes of HDAC inhibitors (hydroxamic acid derivatives, aminobenzamide, cyclic peptide and short-chain fatty acids) that are in clinical trials and different computer modeling tools available for their structural modifications as a guide to discover additional HDAC inhibitors with greater therapeutic utility. Fatty Acids, Volatile histone deacetylase 9 Homo sapiens